Related Experiment Video
Updated: Nov 14, 2025

12:03
Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells
Published on: July 23, 2017
9.7K
Anti-tick and pathogen transmission blocking vaccines.
1U.S. Biologic Inc., Memphis, TN, USA.
Parasite Immunology
|March 11, 2021
Summary
Developing vaccines against ticks and tick-borne diseases is crucial for public health. Research using proteomic and transcriptomic analyses identifies potential vaccine candidates to protect humans and animals.
Area of Science:
- Veterinary Public Health
- Parasitology
- Immunology
Background:
- Ticks and tick-borne diseases pose significant threats to human and animal health.
- Current control methods rely on repellents and acaricides, facing challenges with resistance and environmental impact.
- Vaccination strategies offer a promising alternative for controlling tick infestations and pathogen transmission.
Purpose of the Study:
- To explore the potential of vaccination strategies for controlling ticks and tick-borne diseases.
- To identify novel vaccine candidates through comparative analyses of tick biological states and host-parasite interactions.
- To assess the feasibility of a One Health approach, including wildlife vaccination, for comprehensive disease control.
Main Methods:
- Proteomic and transcriptomic analyses of ticks in different physiological states (unfed/engorged, uninfected/infected).
- Comparative analysis of tick saliva components and host immune responses.
- Evaluation of potential antigens for anti-tick and pathogen transmission-blocking vaccines.
Main Results:
- Comparative analyses revealed key differences in tick proteins and gene expression, highlighting potential vaccine targets.
- Understanding the interplay between tick saliva and host immunity identified promising antigens.
- Vaccination strategies targeting hosts (humans, companion animals, livestock) and wildlife reservoirs show potential for reducing tick populations and disease transmission.
Conclusions:
- Vaccination represents a viable strategy to combat ticks and tick-borne diseases, complementing existing control measures.
- Targeting specific antigens identified through omics approaches can lead to effective anti-tick vaccines.
- A One Health approach, including wildlife vaccination, is a promising avenue for integrated tick-borne disease management, though formulation and regulatory hurdles must be addressed.
Related Concept Videos
Vaccinations
49.1K
Overview
49.1K
Cancer Vaccines
617
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
617
Microorganisms in Medicine and Therapeutics
638
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
638
Infection
9.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
9.8K

